Disclaimer: This is not financial advice. Data sourced from SEC EDGAR and Polygon.io. Past performance does not guarantee future results. Always conduct your own research before making investment decisions.
Precision BioSciences, Inc. Common Stock (DTIL) has a market cap of $186.56M with year-over-year revenue growth of +41.0%. Net margin stands at 10.4%. The stock trades at a P/E ratio of 26.0.
Compared to other companies in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector, DTIL posted revenue growth of +41.0% and trades at a P/E of 26.0.
Disclaimer: This is not financial advice. Data sourced from SEC EDGAR and Polygon.io. Past performance does not guarantee future results. Always conduct your own research before making investment decisions.